Hepatitis C Antibodies among Blood Donors, Senegal, 2001 [2]

Emerging Infectious Diseases

Volumn 9, Issue 11, 2003, Pages 1492-1493

  Etard, Jean François ^a   Colbachini, Pierre ^b   Dromigny, Jacques Albert ^c   Perrier Gros Claude, Jean David ^c  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^b HÔPITAL PRINCIPAL DE DAKAR   (Senegal)

^c INSTITUT PASTEUR DE DAKAR   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS C ANTIBODY;

AGE DISTRIBUTION; ANTIBODY DETECTION; BLOOD DONOR; CLINICAL TRIAL; ENZYME IMMUNOASSAY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; LETTER; META ANALYSIS; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SAFETY; SENEGAL;

EID: 0242355061     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0911.030191     Document Type: Letter

References (10)

1. Ruggieri A, Argentini C, Kouruma F, Chionne P, d'Ugo E, Spada E, et al. Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J Gen Virol 1996;77:2073-6.
2. Jeannel D, Fretz C, Traore Y, Kohdjo N, Bigot A, Pe GE, et al. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol 1998;55:92-7.
3. Wansbrough-Jones M, Frimpong E, Cant B, Harris K, Evans M, Teo C. Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. Trans R Soc Trop Med Hyg 1998;92:496-9.
4. Baïdy Lo B, Meymouna M, Boulahi M, Tew M, Sow A, Ba A, et al. Prévalence des marqueurs sériques des virus des hépatites B et C chez les donneurs de sang à Nouakchott, Mauritanie. Bull Soc Pathol Exot 1999;92:83-4.
5. Madhava V, Burgess C, Drucker E. Epidemiologiy of chronic hepatitis C virus infection in Sub-Saharan Africa. Lancet Infect Dis 2002;2:293-302.
6. Mbaye P, Renaudineau Y, Diallo A, Haudreychy D, Sane M, Michel G, et al. Virus de l'hépatite C et hépatopathies chroniques à Dakar: etude cas-témoins. Med Trop 2000;60:47-52.
7. Diouf M, Diouf B, Seck A, Raphenon G, Moreira-Diop T. Génotype du virus de l'hépatite C chez les malades hémodialysés chroniques de Dakar. Gastroenterol Clin Biol 1999;23:1261-2.
8. Laurent C, Diakhate N, Gueye NF, Toure MA, Sow PS, Faye MA, et al. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS 2002;16:1363-70.
9. Loubière S, Rotily M, Moatti J. Evaluation économique du dépistage et du traitement de l'hépatite C. Med Sci 2002;18:325-33.
10. Creese A, Floyd K, Alban A, Guinness L. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 2002;359:1635-42.